Beta and Trial Use. If Cisco grants You Usage Rights in the applicable Cisco Technology on a trial, evaluation, beta or other free-of-charge basis (“Evaluation Software and Services”), You may only use the Evaluation Software and Services on a temporary basis for the period limited by the license key or specified by Cisco in writing. If there is no period identified, such use is limited to 30 days after the Evaluation Software and Services are made available to You. If You fail to stop using and/or return the Evaluation Software and Services or the equipment on which it is authorized for use by the end of the trial period, You may be invoiced for its list price and agree to pay such invoice. Cisco, in its discretion, may stop providing the Evaluation Software and Services at any time, at which point You will no longer have access to any related data, information, and files and must immediately cease using the Cisco Technology. The Evaluation Software and Services may not have been subject to Cisco’s usual testing and quality assurance processes and may contain bugs, errors, or other issues. Except where agreed to in writing by Xxxxx, You will not put Evaluation Software and Services into production use. Cisco provides Evaluation Software and Services “AS-IS” without support or any express or implied warranty or indemnity for any problems or issues, and Cisco will not have any liability relating to Your use of the Evaluation Software and Services.
Beta and Trial Use. If Axis grants You Usage Rights in the applicable Axis Technology on a trial, evaluation, pre-view, beta or other free-of-charge basis (“Evaluation Software and Services”), You may only use the Evaluation Software and Services on a temporary basis for the period limited by the license key or specified by Axis in writing. If there is no period identified, such use is limited to 30 days after the Evaluation Software and Services are made available to You. If You fail to stop using and/or return the Evaluation Software and Services by the end of the trial period, You may be invoiced for its list price and agree to pay such invoice. Axis, in its discretion, may stop providing the Evaluation Software and Services at any time, at which point You will no longer have access to any related data, information, and files and must immediately cease using the Axis Technology. The Evaluation Software and Services may not have been subject to Axis’ usual testing and quality assurance processes and may contain bugs, errors, or other issues. Axis provides Evaluation Software and Services “AS-IS” without support or any express or implied warranty or indemnity for any problems or issues, and Axis will not have any liability relating to Your use of the Evaluation Software and Services.
Beta and Trial Use. If Cisco grants You Usage Rights in Cisco Technology on a trial, evaluation, beta or other free-of-charge basis (“Evaluation Software and Services”):
Beta and Trial Use. If SWS grants You Usage Rights in the applicable SWS Technology on a trial, evaluation, beta or other free-of- charge basis (“Evaluation Software and Services”), You may only use the Evaluation Software and Services on a temporary basis for the period limited by the license key or specified by SWS in writing. If there is no period identified, such use is limited to 30 days after the Evaluation Software and Services are made available to You. If You fail to stop using and/or return the Evaluation Software and Services or the equipment on which it is authorized for use by the end of the trial period, You may be invoiced for its list price and agree to pay such invoice. SWS, in its discretion, may stop providing the Evaluation Software and Services at any time, at which point You will no longer have access to any related data, information, and files and must immediately cease using the SWS Technology. The Evaluation Software and Services may not have been subject to SWS’s usual testing and quality assurance processes and may contain bugs, errors, or other issues. Except where agreed to in writing by SWS, You will not put Evaluation Software and Services into production use. SWS provides Evaluation Software and Services “AS-IS” without support or any express or implied warranty or indemnity for any problems or issues, and SWS will not have any liability relating to Your use of the Evaluation Software and Services.
Beta and Trial Use. If You are licensed the Software by Quick Heal for evaluation purposes, Your use of the Software is permitted only in a non-production / non-commercial environment unless otherwise permitted earlier by Quick Heal in writing. If Quick Heal provides You access to generally available Software for limited, temporary trial use, Your use is permitted for the period limited by the License Key or by Quick Heal in writing. Notwithstanding the foregoing, Quick Heal, in its discretion, may end the beta or trial at any time, at which point You shall no longer have access to the Software, any related data, information, and files and You should immediately cease any further use. Furthermore, notwithstanding anything contained to the contrary in this Agreement, beta and trial versions of the Software are provided “AS-IS” without any express or implied warranty or indemnity and Quick Heal shall not have any liability relating to Your use of the Software. In the event You opt for the commercialized version of the Software by paying License Fee to Quick Heal, the terms and conditions of this Agreement shall apply mutatis mutandis to Your use of the Software. PRODUCTS BY QUICK HEAL FOR GOVERNMENT DEPARTMENT OR AN ACCREDITED EDUCATIONAL INSTITUTION: It is expressly clarified that certain of Quick Heal’s Software, as confirmed in the Entitlement Confirmation, are products designed specifically for use by end-users in the capacity of government department or an accredited educational institution. Quick Heal reserves the right in its sole discretion to immediately block or deactivate the license key of such Software, if the same is used by You if you are an end-user in any other capacity. The foregoing shall be without prejudice to the rights and remedies available to Quick Heal under this Agreement and at law.
Beta and Trial Use. Beta versions of Cisco products may contain bugs, errors, or other issues. Therefore, they may not be used in Your production environment(s) unless otherwise permitted by Cisco in writing. If we provide You access to generally-available Cisco products for limited, temporary trial use, Your use is permitted for the period limited by the license key or by Cisco in writing. If there is no period identified, any trial use will expire thirty (30) days after the product is made available to You. If You fail to either return the product or stop using it (if it is virtual Software or a Cloud Service) by the end of the trial period, You will be invoiced for the list price of the product. Notwithstanding the foregoing, Cisco, in its discretion, may end the beta or trial at any time, at which point You will no longer have access to any related data, information, and files and You should immediately cease any further use. Furthermore, beta and trial products are provided “AS-IS” without support or any express or implied warranty or indemnity for any problems or issues, and Cisco will not have any liability relating to Your use of the Cisco products.
Beta and Trial Use. Subject to this Agreement and to the terms (if any) presented to You for beta and/or trial use, You may access and use the Application and related services on a trial basis (“Trial”). Your use of the Trial will be for the period stated when you accept the Trial, or if no time is stated, for thirty (30) days from the date access is granted. TRIALS ARE PROVIDED BY HTC “AS-IS” WITH NO WARRANTIES OR INDEMNIFICATIONS. ANY DATA YOU ENTER OR THAT IS COLLECTED DURING TRIAL USE WILL NOT BE STORED OR AVAILABLE AFTER THE TRIAL ENDS.
Beta and Trial Use. If You are licensed the Software by Guardian for evaluation purposes, Your use of the Software is permitted only in a non-production / non-commercial environment unless otherwise permitted earlier by Guardian in writing. If Guardian provides You access to generally available Software for limited, temporary trial use, Your use is permitted for the period limited by the License Key or by Guardian in writing. Notwithstanding the foregoing, Guardian, in its discretion, may end the beta or trial at any time, at which point You shall no longer have access to the Software, any related data, information, and files and You should immediately cease any further use. Furthermore, notwithstanding anything contained to the contrary in this Agreement, beta and trial versions of the Software are provided “AS-IS” without any express or implied warranty or indemnity and Guardian shall not have any liability relating to Your use of the Software. In the event You opt for the commercialized version of the Software by paying License Fee to Guardian, the terms and conditions of this Agreement shall apply mutatis mutandis to Your use of the Software. PRODUCTS BY GUARDIAN FOR GOVERNMENT DEPARTMENT OR AN ACCREDITED EDUCATIONAL INSTITUTION: It is expressly clarified that certain of Guardian’s Software, as confirmed in the Entitlement Confirmation, are products designed specifically for use by end-users in the capacity of government department or an accredited educational institution. Guardian reserves the right in its sole discretion to immediately block or deactivate the license key of such Software, if the same is used by You if you are an end-user in any other capacity. The foregoing shall be without prejudice to the rights and remedies available to Guardian under this Agreement and at law.
Beta and Trial Use. If Cisco grants You Usage Rights in the applicable Cisco Technology on a trial, evaluation, beta or other free-of-charge basis (“Trial Services”), You may only use Trial Services on a temporary basis for the period limited specified by Cisco in writing. If there is no period identified, such use is limited to 30 days after the Trial Services are made available to You. If You fail to stop using and/or return the Trial Services or the equipment on which it is authorized for use by the end of the trial period, You may be invoiced for its list price and agree to pay such invoice. Cisco, in its discretion, may stop providing the Trial Services at any time, at which point You will no longer have access to the Trial Services or any related data. The Trial Services may not have been subject to Cisco’s usual testing and quality assurance processes and may contain bugs, errors, or other issues. Cisco provides Trial Services “AS-IS” without support or any express or implied warranty or indemnity for any problems or issues, and Cisco will not have any liability relating to Your use of any Trial Services.
Beta and Trial Use. If EnGenius allows you to use EnGenius Cloud on a trial, evaluation, beta, or other free-of-charge basis (“Evaluation Software and Services”), you may only use the Evaluation Software and Services on a temporary basis for the period limited by the license key or specified by EnGenius in writing. If there is no period identified, such use is limited to 30 days after the Evaluation Software and Services are made available to you. If you fail to stop using the Evalua- tion Software and Services or the equipment on which it is authorized for use by the end of the trial period, EnGenius may invoice you for your use and you agree to pay such invoice. EnGenius, in its discretion, may stop providing the Evaluation Software and Services at any time, at which point you must immediately cease using EnGenius Cloud. The Evaluation Software and Services may not have been subject to EnGenius’s usual testing and quality assurance processes and may contain bugs, errors, or other issues. Except where agreed to in writing by EnGenius, you will not put Evaluation Software and Services into production use. EnGenius provides Evaluation Software and Services “AS-IS” without support or any express or implied warranty or indemnity for any problems or issues, and EnGenius will not have any liability relating to your use of the Evaluation Software and Services.
